Literature DB >> 26608706

Modulation of glucocorticoid, mineralocorticoid and androgen production in H295 cells by Trimesemine™, a mesembrine-rich Sceletium extract.

A C Swart1, C Smith2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Stress-related illnesses rate among the most prevalent non-fatal diseases globally. With the global trend for consumer bias towards natural medicine, the Sceletium plant has become more prominent in the field of natural products. Although potentially useful effects of Sceletium tortuosum on the central nervous system have been reported, limited data is available on effects of the plant in the peripheral compartment. AIM OF THE STUDY: The current study aimed to elucidate the effect(s) of a Sceletium extract (TRI) rich in mesembrine (1% of plant extract w/w), on adrenal steroid biosynthesis.
MATERIALS AND METHODS: Steroidogenesis was assessed basally and in response to stimuli (forskolin, angiotensin II, KCl), in human adrenocortical carcinoma cells (H295R). Steroid hormone levels were assessed using UPLC-MS/MS. UPLC-MS analyses of TRI identified major alkaloids Δ7-mesembrenone, mesembrenone and mesembrine.
RESULTS: Highest dose TRI treatment (1 mg/ml, 34.5 μM mesembrine) increased pregnenolone and decreased 16-hydroxyprogesterone levels (both P<0.00001) in forskolin-stimulated conditions only, suggesting CYP17 enzyme inhibition. This led to significant inhibition of forskolin-associated increases in cortisol levels at the highest dose (P<0.001) and basal cortisol levels across all doses (P<0.0001). Independently of forskolin, TRI inhibited androstenedione and testosterone production across all doses (both P<0.00001), suggesting inhibition of 3βHSD and 17βHSD respectively. TRI decreased both the angiotensin II- (P<0.05) and forskolin-induced (P<0.0001) increases in aldosterone production.
CONCLUSIONS: Our data suggest potentially beneficial effects of TRI in the context of stress and hypertension. These should be further investigated in a whole organism model, while the effects on the androgenic pathway should also be further elucidated.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adrenal steroidogenesis; Alkaloid; Anxiolytic; Cortisol; Cytochrome p450; Endocrine disrupting compound; Hypertension; Sceletium tortuosum; Stress

Mesh:

Substances:

Year:  2015        PMID: 26608706     DOI: 10.1016/j.jep.2015.11.033

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

Review 1.  Natural antioxidants in prevention of accelerated ageing: a departure from conventional paradigms required.

Authors:  Carine Smith
Journal:  J Physiol Biochem       Date:  2018-03-14       Impact factor: 4.158

2.  Sceletium tortuosum may delay chronic disease progression via alkaloid-dependent antioxidant or anti-inflammatory action.

Authors:  A C Bennett; A Van Camp; V López; C Smith
Journal:  J Physiol Biochem       Date:  2018-03-09       Impact factor: 4.158

Review 3.  Bioactive Natural Products against Systemic Arterial Hypertension: A Past 20-Year Systematic and Prospective Review.

Authors:  Maisa Gomes da Silva; Sara Léa Fortes Barbosa; Diego Santos Silva; Isadora Basílio Meneses Bezerra; Érika Alves Bezerra; Angélica Gomes Coelho; Ilmara Cecília Pinheiro da Silva Morais; Luis Mário Rezende-Júnior; Iolanda Souza do Carmo; José de Sousa Lima-Neto; Simón Gabriel Comerma-Steffensen; Antônia Maria das Graças Lopes Citó; Daniel Dias Rufino Arcanjo
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-20       Impact factor: 2.650

Review 4.  A Chewable Cure "Kanna": Biological and Pharmaceutical Properties of Sceletium tortuosum.

Authors:  Madira Coutlyne Manganyi; Cornelius Carlos Bezuidenhout; Thierry Regnier; Collins Njie Ateba
Journal:  Molecules       Date:  2021-04-28       Impact factor: 4.411

5.  Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems.

Authors:  Thomas Brendler; Josef A Brinckmann; Ulrich Feiter; Nigel Gericke; Lucy Lang; Olga N Pozharitskaya; Alexander N Shikov; Michael Smith; Ben-Erik Van Wyk
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.